vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and John Marshall Bancorp, Inc. (JMSB). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $16.8M, roughly 1.3× John Marshall Bancorp, Inc.). John Marshall Bancorp, Inc. runs the higher net margin — 36.3% vs -373.3%, a 409.6% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.
AUTL vs JMSB — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $21.2M | $16.8M |
| Net Profit | $-79.1M | $6.1M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | — |
| Net Margin | -373.3% | 36.3% |
| Revenue YoY | — | — |
| Net Profit YoY | 3.6% | 26.8% |
| EPS (diluted) | $-0.30 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $16.8M | ||
| Q4 25 | — | $16.4M | ||
| Q3 25 | $21.2M | $16.3M | ||
| Q2 25 | $20.9M | $15.4M | ||
| Q1 25 | $9.0M | $14.6M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $0 | $13.8M | ||
| Q2 24 | $0 | $12.6M |
| Q1 26 | — | $6.1M | ||
| Q4 25 | — | $5.9M | ||
| Q3 25 | $-79.1M | $5.4M | ||
| Q2 25 | $-47.9M | $5.1M | ||
| Q1 25 | $-70.2M | $4.8M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | $-82.1M | $4.2M | ||
| Q2 24 | $-58.3M | $3.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 47.4% | ||
| Q3 25 | -337.9% | 42.2% | ||
| Q2 25 | -292.6% | 42.7% | ||
| Q1 25 | -726.3% | 42.4% | ||
| Q4 24 | — | 42.5% | ||
| Q3 24 | — | 38.8% | ||
| Q2 24 | — | 39.7% |
| Q1 26 | — | 36.3% | ||
| Q4 25 | — | 36.2% | ||
| Q3 25 | -373.3% | 33.2% | ||
| Q2 25 | -229.0% | 33.1% | ||
| Q1 25 | -781.1% | 32.9% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | — | 30.9% |
| Q1 26 | — | $0.43 | ||
| Q4 25 | — | $0.41 | ||
| Q3 25 | $-0.30 | $0.38 | ||
| Q2 25 | $-0.18 | $0.36 | ||
| Q1 25 | $-0.26 | $0.34 | ||
| Q4 24 | — | $0.33 | ||
| Q3 24 | $-0.31 | $0.30 | ||
| Q2 24 | $-0.22 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $150.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $268.1M |
| Total Assets | $661.9M | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $150.2M | ||
| Q4 25 | — | $130.0M | ||
| Q3 25 | $86.1M | $163.6M | ||
| Q2 25 | $123.8M | $116.9M | ||
| Q1 25 | $95.8M | $169.1M | ||
| Q4 24 | — | $122.5M | ||
| Q3 24 | $657.1M | $177.2M | ||
| Q2 24 | $705.9M | $182.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $80.9M | ||
| Q3 25 | — | $80.9M | ||
| Q2 25 | — | $80.8M | ||
| Q1 25 | — | $80.8M | ||
| Q4 24 | — | $80.8M | ||
| Q3 24 | — | $80.8M | ||
| Q2 24 | — | $24.7M |
| Q1 26 | — | $268.1M | ||
| Q4 25 | — | $265.6M | ||
| Q3 25 | $265.5M | $259.7M | ||
| Q2 25 | $346.5M | $253.7M | ||
| Q1 25 | $371.1M | $253.0M | ||
| Q4 24 | — | $246.6M | ||
| Q3 24 | $477.0M | $243.1M | ||
| Q2 24 | $527.8M | $235.3M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | $661.9M | $2.3B | ||
| Q2 25 | $721.0M | $2.3B | ||
| Q1 25 | $746.3M | $2.3B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $827.5M | $2.3B | ||
| Q2 24 | $853.6M | $2.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.33× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | — |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $22.6M | ||
| Q3 25 | $-67.9M | $1.2M | ||
| Q2 25 | $-72.8M | $7.5M | ||
| Q1 25 | $-75.6M | $7.0M | ||
| Q4 24 | — | $17.3M | ||
| Q3 24 | $-76.7M | $1.4M | ||
| Q2 24 | $-51.1M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $22.0M | ||
| Q3 25 | $-72.3M | $1.2M | ||
| Q2 25 | $-80.1M | $7.4M | ||
| Q1 25 | $-83.8M | $6.6M | ||
| Q4 24 | — | $16.8M | ||
| Q3 24 | $-86.3M | $1.3M | ||
| Q2 24 | $-51.9M | $10.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 134.7% | ||
| Q3 25 | -341.2% | 7.3% | ||
| Q2 25 | -382.6% | 47.8% | ||
| Q1 25 | -933.1% | 45.3% | ||
| Q4 24 | — | 116.9% | ||
| Q3 24 | — | 9.5% | ||
| Q2 24 | — | 80.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.4% | ||
| Q3 25 | 20.8% | 0.2% | ||
| Q2 25 | 34.8% | 1.0% | ||
| Q1 25 | 91.8% | 2.3% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.82× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.45× | ||
| Q4 24 | — | 3.61× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 2.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
JMSB
| Net Interest Income | $16.5M | 98% |
| Noninterest Income | $284.0K | 2% |